Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure: A systematic review

Journal of the American College of Cardiology

Volumn 59, Issue 8, 2012, Pages 719-726

  Ganesan, Anand N ^a   Brooks, Anthony G ^a   Roberts Thomson, Kurt C ^a   Lau, Dennis H ^a   Kalman, Jonathan M ^b   Sanders, Prashanthan ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

atrial fibrillation; biventricular pacing; cardiac resynchronization; heart failure; systematic review

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; COMORBIDITY; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HEART ATRIOVENTRICULAR NODE ABLATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART SURGERY; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QRS COMPLEX; SYSTEMATIC REVIEW; SYSTOLIC DYSFUNCTION;

ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; HEART FAILURE; HUMANS; TREATMENT OUTCOME;

EID: 84856834043     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.10.891     Document Type: Article

References (28)

1. T.J. Wang, M.G. Larson, D. Levy Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925 (Pubitemid 36736633)
2. K. Dickstein, P.E. Vardas, A. Auricchio 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Europace 12 2010 1526 1536
3. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 2008 e1 e62
4. F.A. McAlister, J. Ezekowitz, N. Hooton Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review JAMA 297 2007 2502 2514 (Pubitemid 46953404)
5. J.S. Steinberg Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation J Am Coll Cardiol 48 2006 744 746
6. S.G. Molhoek, J.J. Bax, G.B. Bleeker Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation Am J Cardiol 94 2004 1506 1509 (Pubitemid 40268451)
7. M. Gasparini, A. Auricchio, F. Regoli Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression The importance of performing atrioventricular junction ablation in patients with atrial fibrillation J Am Coll Cardiol 48 2006 734 743 (Pubitemid 44175735)
8. P. Kies, C. Leclercq, G.B. Bleeker Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm Heart 92 2006 490 494
9. P.P. Delnoy, J.P. Ottervanger, H.O. Luttikhuis Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure Am J Cardiol 99 2007 1252 1257 (Pubitemid 46659863)
10. A.M. Ferreira, P. Adragao, D.M. Cavaco Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation Europace 10 2008 809 815 (Pubitemid 351882072)
11. M. Gasparini, A. Auricchio, M. Metra Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation Eur Heart J 29 2008 1644 1652 (Pubitemid 351957539)
12. K. Khadjooi, P.W. Foley, S. Chalil Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation Heart 94 2008 879 883 (Pubitemid 351914698)
13. J.M. Tolosana, A. Hernandez Madrid, J. Brugada Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm Am J Cardiol 102 2008 444 449
14. K. Dong, W.-K. Shen, B.D. Powell Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy Heart Rhythm 7 2010 1240 1245
15. C. Leclercq, S. Walker, C. Linde Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation Eur Heart J 23 2002 1780 1787 (Pubitemid 35334271)
16. C. Linde, C. Leclercq, S. Rex Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation In Cardiomyopathy (MUSTIC) study J Am Coll Cardiol 40 2002 111 118 (Pubitemid 34701385)
17. G.A. Upadhyay, N.K. Choudhry, A. Auricchio, J. Ruskin, J.P. Singh Cardiac resynchronization in patients with atrial fibrillation A meta-analysis of prospective cohort studies J Am Coll Cardiol 52 2008 1239 1246
18. S.B. Wilton, A.A. Leung, W.A. Ghali, P. Faris, D.V. Exner Outcomes of cardiac resynchronization therapy in patients with versus without atrial fibrillation: a systematic review and meta-analysis Heart Rhythm 8 2011 1088 1094
19. K. Dickstein, N. Bogale, S. Priori The European cardiac resynchronization therapy survey Eur Heart J 30 2009 2450 2460
20. G.S. Kamath, D. Cotiga, J.N. Koneru The utility of 12-lead holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy J Am Coll Cardiol 53 2009 1050 1055
21. M. Gasparini, P.C. Block Efficacy of CRT on exercise tolerance and disease progression: the importance of AV junction ablation in patients with atrial fibrillation ACC Cardiosource Rev J 15 2006 39 42 (Pubitemid 46647010)
22. M. Gasparini, F. Regoli, P. Galimberti, C. Ceriotti, A. Cappelleri Cardiac resynchronization therapy in heart failure patients with atrial fibrillation Europace 11 Suppl 5 2009 v82 v86
23. G.A. Wells, B. Shea, D. O'Connell The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp Accessed January 3, 2012
24. K.C. Ueng, T.P. Tsai, C.F. Tsai Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response J Cardiovasc Electrophysiol 12 2001 303 309
25. M.A. Wood, C. Brown-Mahoney, G.N. Kay, K.A. Ellenbogen Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis Circulation 101 2000 1138 1144 (Pubitemid 30146615)
26. D.L. Hayes, J.P. Boehmer, J. Day et al. Percent biventricular pacing impacts mortality in heart failure patients Heart Rhythm 6 2009 S134
27. B.A. Koplan, A.J. Kaplan, S. Weiner, P.W. Jones, M. Seth, S.A. Christman Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 53 2009 355 360
28. M. Santini, M. Gasparini, M. Landolina Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators J Am Coll Cardiol 57 2011 167 172